Welcome to our dedicated page for CME Group SEC filings (Ticker: CME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CME Group Inc. SEC filings document the financial results, governance matters and market-infrastructure disclosures of a derivatives exchange and clearing operator. Form 8-K reports cover quarterly and annual results, GAAP and non-GAAP measures, pricing disclosures, material agreements and other events tied to the company’s trading, clearing, benchmark and market data activities.
The filings also describe clearing-house liquidity arrangements, including amendments to a multi-currency secured credit facility used for temporary liquidity needs related to clearing obligations and collateral mechanics. Proxy materials cover executive compensation, pay-versus-performance data, shareholder voting matters and governance. Other event reports have addressed officer transition disclosures and legal matters involving CME Group and the Board of Trade of the City of Chicago.
CME Group Inc. senior managing director and Chief HR Officer Hilda Harris Piell reported an open-market sale of 5,753 shares of Class A common stock at an average price of $304.63 per share. Following this transaction, she directly holds 27,702 shares of CME Group stock.
CME Group Inc. held its 2026 annual meeting of shareholders on May 14, 2026, and reported the voting results. Shareholders representing 318,466,544 shares, or 87.78% of the 362,808,081 Class A and Class B shares outstanding as of March 16, 2026, were present in person or by proxy. Class B-1, B-2, B-3 and B-4 did not reach their required 33.3% quorum, so the proposals under Items 4 through 8 were adjourned to a virtual meeting on June 9, 2026. Equity director nominees were elected with strong majorities, and shareholders ratified Ernst & Young LLP as independent auditor for 2026. On an advisory basis, shareholders also approved compensation for the company’s named executive officers.
CME affiliate filed a Form 144 proposing the sale of Common shares.
The filing lists multiple lots of issuer‑granted securities described as Restricted Stock and Performance Shares with grant dates from 09/14/2020 through 03/15/2025. The record shows lot sizes such as 512 shares (09/14/2020) and 2,015 shares (03/15/2025) and a filing date of 05/18/2026.
CME Group Inc. Chairman and CEO Terrence A. Duffy reported selling a total of 35,000 shares of Class A common stock in open-market transactions on May 15, 2026. The sales occurred in two blocks: 9,004 shares at a weighted average price of $299.58 per share and 25,996 shares at a weighted average price of $298.14 per share.
According to the footnotes, each reported price is a weighted average for multiple trades, with actual sale prices ranging from $298.00 to $298.89 for one block and $299.00 to $299.95 for the other. The filing indicates these were standard open-market sales of non-derivative common stock.
CME Group Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 27,044,709 shares of Common Stock, equal to 7.45% of the class as reported for the period ending 03/31/2026.
The filing states Vanguard has sole dispositive power over 27,044,709 shares and sole voting power for 3,677,427 shares. The filing describes holdings held on behalf of various Vanguard affiliates and funds. Signature on the filing is dated 04/29/2026.
CME Group Inc., through its subsidiary Chicago Mercantile Exchange Inc., entered into Amendment No. 11 to its 364-day multi-currency credit facility with a syndicate of banks led by Bank of America and Citibank. The amended facility provides a $7 billion multi-currency revolving secured credit line, which is eligible to be increased to $10 billion. It is intended to provide temporary liquidity if a clearing firm or depositary fails to meet obligations, or if there is a disruption in the domestic payments system affecting settlements between CME and its clearing firms. Cash and U.S. Treasury guaranty fund contributions, along with performance bond assets under the CME rulebook, may be used as collateral, and CME must comply with a consolidated tangible net worth test.
CME Group Inc. reported strong first-quarter 2026 results with higher trading activity and earnings. Total revenues rose to $1,880.1 million, up 14% from $1,642.3 million a year earlier, driven mainly by clearing and transaction fees of $1,542.6 million, up 15%.
Operating expenses increased 7% to $570.4 million, but operating income still climbed to $1,309.7 million from $1,108.0 million, lifting the operating margin to 69.7%. Net income grew to $1,154.3 million, up 21%, and diluted earnings per share improved to $3.18 from $2.62.
Higher investment income from performance bond and guaranty fund balances contributed to non‑operating income of $201.2 million. CME continued returning capital, paying common dividends of about $2,702.9 million and repurchasing 1.84 million Class A shares for roughly $538.7 million under its $3.0 billion buyback authorization.
CME Group Inc. reported record first-quarter 2026 results, with revenue of $1.88 billion, up 14% from a year earlier. Operating income rose to $1.31 billion, while net income reached $1.15 billion and diluted earnings per share were $3.18.
On a non-GAAP basis, adjusted operating income was $1.37 billion, adjusted net income was $1.22 billion and adjusted diluted EPS were $3.36, each at record levels. Trading activity was exceptionally strong, with average daily volume hitting an all-time high of 36.2 million contracts, up 22%, and non-U.S. volume rising 30%. The company also returned significant capital, paying approximately $2.7 billion in dividends and repurchasing $536 million of shares in the quarter.
CME Group Inc. director William R. Shepard reported buying a net 1,469.84 shares of Class A common stock at $297.38 per share. The purchases on March 26, 2026 included 1,407.78 shares acquired indirectly through a trust and 62.06 shares acquired in his direct account.
The indirectly held shares rose to 260,117.54 held by a trust, while directly held shares increased to 2,539.45. A footnote explains that the acquired shares reflect a dividend reinvestment plan administered by his broker, meaning cash dividends were automatically used to buy additional CME shares.